ImmuPharma raises £1.5m from share issue to fund R&D

Mon, 30th Mar 2020

Specialist drug developer ImmuPharma said it had raised £1.5m via a share issue to support an expansion of its R&D pipeline. New shares in the company were offered at 10p each to existing shareholder Lanstead Capital Investors and chief scientific officer Robert Zimmer. At 2:38pm: (LON:IMM) ImmuPharma PLC share price was -0.31p at 10.38p Story provided by

FTSE 100 Latest